Folate (Vitamin B9) Deficiency: Neural Tube Defects (Pregnancy)

Of everything folate (vitamin B9) does in the body, this is the one with the highest stakes and the clearest, most life-changing payoff. In the first few weeks of pregnancy — often before a woman even knows she is pregnant — a flat sheet of cells folds itself into a tube that becomes the baby's brain and spinal cord. That tube has to seal shut completely, and it does so by about day 28 after conception. When folate is in short supply during that narrow window, the tube can fail to close, producing a neural tube defect (NTD) such as spina bifida (an open spine) or anencephaly (a fatal failure of the skull and brain to form). The remarkable part is how preventable much of this is: taking 400 micrograms of folic acid every day, starting before you conceive, sharply lowers the risk — a finding proven in a landmark 1991 trial and confirmed by national food-fortification programs that cut NTD rates substantially. This page explains how the spine closes, why timing is everything, who needs a higher dose, and exactly what to do.

Table of Contents

  1. What This Looks Like — and Why It's Silent
  2. The Mechanism: How Folate Builds and Closes the Neural Tube
  3. Why Timing Is Everything: The Day-28 Window
  4. Honesty: Folate Is Not the Only Factor
  5. Who Needs the Higher 4–5 mg Dose
  6. Why Folate Runs Low Before and During Pregnancy
  7. The Evidence: MRC 1991 and Food Fortification
  8. Screening, Diagnosis, and Lab Tests
  9. What To Do: Doses, Food, and Forms
  10. When to Seek Care / Red Flags
  11. Key Research Papers
  12. Connections
  13. Featured Videos

What This Looks Like — and Why It's Silent

This is unlike every other symptom of folate deficiency on this site, and it is important to be honest about why. A neural tube defect is not something the mother feels. There is no ache, no warning sign, no sensation that tells a woman her folate is too low for the baby's developing spine. The deficiency does its damage quietly, inside the embryo, during the few weeks when the neural tube is forming — and the result is only discovered later, on an ultrasound or a blood test, or at birth.

That silence is the whole problem. By the time a pregnancy is confirmed — usually after a missed period, around 4 to 6 weeks of gestation — the most critical part of neural tube closure has often already happened or is finishing. A woman can do everything right the moment she sees a positive test and still be too late to influence this particular event, because the window opened and closed before she knew to act. This is exactly why the advice is not “take folic acid when you find out you're pregnant” but rather “take it before you conceive” — ideally for at least a month beforehand, and through the first trimester.

When an NTD does occur, what it looks like depends on the type and severity:

The point of this page is not to frighten anyone who is already pregnant and hasn't been taking folic acid. The reality is reassuring in a different way: NTDs are uncommon (roughly 1 in 1,000 pregnancies in many countries before fortification, lower now), and the single most powerful thing known to reduce them — adequate folate around conception — is cheap, safe, and available without a prescription. The message is about preparation, not blame.

Back to Table of Contents

The Mechanism: How Folate Builds and Closes the Neural Tube

To understand why folate matters here, it helps to picture what is physically happening. Very early in development, the embryo is essentially a flat, layered disc. Along its midline, a strip of cells called the neural plate begins to thicken, then fold upward at the edges like a piece of paper being rolled into a tube. The two raised edges (the neural folds) rise, lean toward each other, and finally fuse along the top, zipping the open groove closed into the neural tube. That tube is the foundation of the entire central nervous system: its head end balloons into the brain, and the rest becomes the spinal cord.

Closure is not a single instant. It works like a zipper that starts in the middle of the back and runs in both directions — up toward the head and down toward the tailbone. The very ends, called the neuropores, are the last to seal. The front (cranial) neuropore closes around day 24–26, and the back (caudal) neuropore around day 26–28. If the zipper jams at the top, you get anencephaly; if it jams at the bottom, you get spina bifida.

Here is where folate comes in. Folding and sealing the neural tube requires an enormous, rapid burst of cell division — the embryo is manufacturing new cells at a furious pace, and each new cell needs a complete new copy of its DNA. Folate is the vitamin that makes building DNA possible. In its active form, folate carries and hands off one-carbon units that are needed to synthesize thymidine and the purine bases — the literal letters of the genetic code. Without enough folate, cells cannot copy their DNA fast enough or accurately enough to keep up with the tissue that is supposed to be forming and fusing. The zipper stalls.

Folate also drives DNA methylation, a chemical tagging system that switches genes on and off at the right time and place. Through the methylation cycle (which converts homocysteine to methionine and produces the universal methyl donor SAM), folate helps orchestrate which genes the embryo's cells turn on as they decide to become brain, spine, or skin. So folate is doing two jobs at once during neural tube closure: providing the raw bricks for new DNA, and providing the chemical signals that tell the construction crew what to build. (For the deeper biochemistry, see Folate, Methylation, and Homocysteine.)

An analogy. Imagine you have only four weeks to build a long, complex bridge, and every steel beam has to be fabricated on site from a special alloy. Folate is the alloy. If the supply is steady, the crew lays beams on schedule and the two halves meet perfectly in the middle. If the alloy runs short for even a few critical days, sections get skipped, the spans don't meet, and you're left with a gap that can never be filled in later — because by then the construction deadline has passed and the crew has moved on to other work. The neural tube has exactly one deadline, and folate has to be present before the work begins.

It is worth adding that folate does not act alone, and NTDs are not caused by a simple, classic vitamin-deficiency state like scurvy. Many women who have a baby with an NTD are not frankly folate-deficient by blood test. The current understanding is that adequate folate raises the threshold of protection for a developing tube that may be vulnerable for genetic or other reasons — it does not mean every NTD is purely a folate-shortage disease. That nuance matters for the honesty section below.

Back to Table of Contents

Why Timing Is Everything: The Day-28 Window

If there is one fact to carry away from this entire page, it is this: the neural tube closes by about day 28 after conception, which is roughly two weeks after a missed period — and for many women, that is before they realize they are pregnant. Folic acid taken after that window cannot reopen and re-close a tube that has already finished forming.

Walk through the calendar. Pregnancy is conventionally dated from the first day of the last menstrual period, but conception happens about two weeks later, around ovulation. So “day 28 after conception” corresponds to roughly 6 weeks of pregnancy by the usual dating — only about two weeks after a period would have been due. A woman with a slightly irregular cycle, or who isn't tracking closely, may not have a positive test, let alone a doctor's visit, until the neural tube is already sealed.

This timing reality drives the central public-health recommendation, echoed by health authorities worldwide: any woman who could become pregnant should take folic acid daily, not just those actively trying. Nearly half of pregnancies are unplanned, and the protective window is too early and too brief to rely on starting after a positive test. The guidance is therefore framed around the possibility of pregnancy, not its confirmation.

How far in advance? The practical answer most guidelines give is to start at least one month before conception and continue through at least the first trimester (the first 12 weeks). Starting earlier is fine and arguably better, because it takes some weeks of daily intake to fully build up red-cell folate — the body's longer-term folate store — to a protective level. There is no benefit to waiting, and no harm in beginning months ahead.

Back to Table of Contents

Honesty: Folate Is Not the Only Factor

It would be misleading to suggest that folic acid prevents all neural tube defects, or that an NTD always means the mother didn't take enough. The honest picture is more layered, and being clear about it protects families from unfair self-blame.

Adequate periconceptional folate reduces the risk of NTDs by a large margin — in high-risk recurrence the landmark trial showed roughly a 70% reduction — but it does not drive the risk to zero. A meaningful share of NTDs are folate-resistant: they occur despite normal folate status and good supplementation. NTDs arise from a complex interaction of genes, nutrition, and environment, and only one strand of that web is folate.

Other recognized contributors and causes include:

The reason this honesty matters: a parent of a child with spina bifida should not conclude they “caused” it by missing vitamins. Many did take folic acid. The vitamin shifts the odds powerfully across a whole population — which is why fortifying the food supply prevented thousands of cases — but for any single pregnancy, it is one important protective factor among several, not a guarantee.

Back to Table of Contents

Who Needs the Higher 4–5 mg Dose

For most women, the standard preventive dose is 400 micrograms (0.4 mg) of folic acid daily. But a defined high-risk group needs roughly ten times more — about 4 to 5 milligrams (4,000–5,000 mcg) daily — and this higher dose should be taken under a clinician's guidance, started ideally one to three months before conception. The high-dose recommendation applies when any of the following is true:

If any of these apply to you, the single most useful thing you can do is have a pre-pregnancy (preconception) conversation with your doctor before stopping contraception. They can confirm the right dose, review your medications (some anti-seizure drugs can sometimes be changed to safer alternatives before pregnancy), and check that diabetes or other conditions are well controlled. This is also the moment to flag the sibling deficiency picture — folate deficiency that produces a low-folate blood state can also cause megaloblastic anemia and fatigue — and to make sure a low vitamin B12 isn't being missed, since the two vitamins are closely linked.

One important caution on high doses: very high folic acid can mask the blood signs of a vitamin B12 deficiency. Folic acid corrects the anemia of B12 deficiency but does nothing for the nerve damage it causes, which can then progress silently. This is one more reason the 4–5 mg dose is a medically supervised dose, not a do-it-yourself decision, and why B12 status is usually checked alongside it.

Back to Table of Contents

Why Folate Runs Low Before and During Pregnancy

Pregnancy is one of the body's highest-demand states for folate, which is exactly why a level that was “fine” beforehand can fall short when it matters most. Several forces pull folate down:

The combination that worries clinicians most is an unplanned pregnancy in someone with low dietary folate and no supplement — precisely the scenario in which the protective window can pass before anyone is paying attention. That is the gap mandatory food fortification was designed to close.

Back to Table of Contents

The Evidence: MRC 1991 and Food Fortification

The link between folate and neural tube defects is one of the best-established cause-and-prevention stories in modern nutrition, built on randomized trials and then confirmed on the scale of whole nations.

The turning point was the Medical Research Council (MRC) Vitamin Study, published in The Lancet in 1991. It was a large, multi-country randomized controlled trial in women who had already had one pregnancy affected by an NTD — the highest-risk group. Women were randomly assigned to take folic acid or not. The result was decisive: folic acid supplementation produced about a 72% reduction in the recurrence of neural tube defects. Because it was randomized, it established cause and effect rather than mere association, and it settled the question for high-risk women.

The following year, a randomized trial by Czeizel and Dudás in the New England Journal of Medicine (1992) extended the finding to first occurrences — women with no prior NTD pregnancy — showing that periconceptional multivitamins containing folic acid prevented the first NTD, not just recurrences. Together these trials made the case for recommending folic acid to all women capable of becoming pregnant.

But recommendations alone reach only the women who are planning ahead. The next leap was fortifying the food supply so that protection didn't depend on remembering a pill. The United States and Canada mandated adding folic acid to enriched grain products (flour, bread, pasta, cereal) in the late 1990s, and many other countries followed. The population results were striking:

Systematic reviews tie it together. A Cochrane review of randomized trials concluded that periconceptional folic acid clearly prevents both first-occurrence and recurrent NTDs, and the US Preventive Services Task Force gives daily folic acid for women planning or capable of pregnancy its strongest (Grade A) recommendation. Few interventions in all of preventive medicine rest on such a consistent chain of evidence — from biology, to randomized trials, to whole-population fortification.

Back to Table of Contents

Screening, Diagnosis, and Lab Tests

There are two very different things being “diagnosed” here, and it helps to keep them separate.

1. Detecting a neural tube defect in an ongoing pregnancy. NTDs are usually found through routine prenatal screening, not through a folate test:

These tests detect an NTD; they cannot prevent one. Prevention happens earlier, before conception, with folate.

2. Checking folate status itself. A blood test can measure folate, but it is most useful for evaluating deficiency (and its anemia) rather than for predicting NTD risk:

For a healthy woman planning a pregnancy, routine folate-level testing is generally not required before recommending folic acid — the advice to supplement is universal precisely because testing isn't a prerequisite. Folate testing and B12 testing become relevant when there are symptoms of deficiency, anemia, malabsorption, or a high-risk situation. (Notably, the genetic MTHFR test is not recommended as a routine pre-pregnancy screen for healthy women.)

Back to Table of Contents

What To Do: Doses, Food, and Forms

The practical plan is refreshingly simple, and it is the same advice given by health authorities around the world.

The core recommendation. Every woman who could become pregnant should take 400 micrograms (0.4 mg) of folic acid daily, beginning at least one month before conception and continuing through the first 12 weeks of pregnancy. If you are actively trying to conceive, start now. A standard prenatal vitamin typically contains this amount (often 400–800 mcg), so a daily prenatal taken before and during early pregnancy covers it.

The high-risk dose. Women in the high-risk groups described above — a prior NTD pregnancy, certain anti-seizure medications, pre-existing diabetes, family history — need about 4 to 5 mg (4,000–5,000 mcg) of folic acid daily, taken under medical supervision, usually starting one to three months before conception. Do not assemble this dose by swallowing many standard prenatals (you would over-consume other vitamins); a clinician prescribes a dedicated high-dose folic acid.

Food matters too, but supplements do the heavy lifting here. Folate-rich foods build a healthy baseline and support overall nutrition, and they should be a regular part of the diet:

The reason food alone is not considered sufficient for NTD prevention is twofold: natural food folate is partly destroyed by cooking and is less efficiently absorbed than the folic acid in supplements and fortified foods, and the protective window is so early and so unforgiving that public-health bodies don't want anyone relying on diet variability. Supplemental or fortified folic acid is the form proven in trials to prevent NTDs. For a fuller list of dietary sources and amounts, see the folate food sources page.

A note on forms (folic acid vs. methylfolate). Some supplements use L-methylfolate (the already-activated form) instead of folic acid, marketed especially to people with MTHFR variants. For the specific goal of NTD prevention, the form with the deepest randomized-trial and population evidence is folic acid — that is what the MRC trial and the fortification programs used. Methylfolate is a reasonable folate source for general purposes, but it does not have the same body of NTD-prevention trial data behind it, and for this single highest-stakes purpose the conventional advice is to use the form that was actually proven to work. If you have a specific reason to prefer methylfolate, discuss the dose with your clinician.

Back to Table of Contents

When to Seek Care / Red Flags

Because the prevention window is before and during very early pregnancy, the most important “red flags” here are really reasons to talk to a clinician sooner rather than later:

And the reassuring counterpart: if you are already pregnant and only just starting folic acid, take it now (it supports many later processes too), keep your prenatal appointments, and talk with your provider rather than worrying alone. Folic acid is extremely safe at recommended doses, and the great majority of pregnancies — including many where folic acid was started late — are unaffected by NTDs.

Back to Table of Contents

Key Research Papers

  1. MRC Vitamin Study Research Group (Wald N, chair) (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. The Lancet;338(8760):131-137. — DOI: 10.1016/0140-6736(91)90133-A
  2. Czeizel AE, Dudás I (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine;327(26):1832-1835. — DOI: 10.1056/NEJM199212243272602
  3. Berry RJ, Li Z, Erickson JD, et al. (1999). Prevention of neural-tube defects with folic acid in China. New England Journal of Medicine;341(20):1485-1490. — DOI: 10.1056/NEJM199911113412001
  4. De Wals P, Tairou F, Van Allen MI, et al. (2007). Reduction in neural-tube defects after folic acid fortification in Canada. New England Journal of Medicine;357(2):135-142. — DOI: 10.1056/NEJMoa067103
  5. De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, Rayco-Solon P (2015). Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews;(12):CD007950. — DOI: 10.1002/14651858.CD007950.pub3
  6. US Preventive Services Task Force (Bibbins-Domingo K, et al.) (2017). Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. JAMA;317(2):183-189. — DOI: 10.1001/jama.2016.19438
  7. Wilson RD, Wilson RD, Audibert F, et al. (2015). Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. Journal of Obstetrics and Gynaecology Canada;37(6):534-549. — DOI: 10.1016/S1701-2163(15)30230-9
  8. Greene NDE, Copp AJ (2014). Neural tube defects. Annual Review of Neuroscience;37:221-242. — DOI: 10.1146/annurev-neuro-062012-170354
  9. Crider KS, Yang TP, Berry RJ, Bailey LB (2012). Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role. Advances in Nutrition;3(1):21-38. — DOI: 10.3945/an.111.000992
  10. Blencowe H, Cousens S, Modell B, Lawn J (2010). Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology;39(Suppl 1):i110-i121. — DOI: 10.1093/ije/dyq028
  11. Williams J, Mai CT, Mulinare J, et al. (CDC) (2015). Updated estimates of neural tube defects prevented by mandatory folic acid fortification — United States, 1995–2011. MMWR Morbidity and Mortality Weekly Report;64(1):1-5. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents